Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

“Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

“The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

For more information, please visit www.thermofisher.com

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

Related Posts

  • Health
  • May 28, 2025
  • 15 views
A New Era in Non-Surgical Facelifts: Sakhiya Skin Clinic Champions the Rise of Thread Lifting

Surat (Gujarat), India, May 27: Non-surgical face rejuvenation has become increasingly popular as more people look for mild and effective aesthetic procedures.  Leading the way with its ground-breaking Definisse Thread…

  • Health
  • May 21, 2025
  • 17 views
How Bangalore Is Fighting Substance Abuse Through Rehabilitation

Bangalore (Karnataka) [India], May 20:  One of the biggest issues related to mental health today is substance abuse, and Bangalore is not free from it. In 2022, the city had…

You Missed

JPrime Buildcon’s Grand Business Meet ‘Sankalp 2025’ Marks a New Chapter in Mumbai 3.0 Growth Story

  • By
  • June 13, 2025
JPrime Buildcon’s Grand Business Meet ‘Sankalp 2025’ Marks a New Chapter in Mumbai 3.0 Growth Story

Surat’s Diamond Shines at Las Vegas: Govindkaka Felicitated at JCK Las Vegas

  • By
  • June 13, 2025
Surat’s Diamond Shines at Las Vegas: Govindkaka Felicitated at JCK Las Vegas

Celebs, Business and Beyond: How The Centrum Hotel Lucknow Became a New Luxury Landmark in India 2025

  • By
  • June 12, 2025
Celebs, Business and Beyond: How The Centrum Hotel Lucknow Became a New Luxury Landmark in India 2025

Ankit Khandelwal: The Relentless Visionary Behind Scalable Impact

  • By
  • June 11, 2025
Ankit Khandelwal: The Relentless Visionary Behind Scalable Impact

Bonhooghly Yubak Sangha’s Roktodan Utsav Sees 2,545 Donors in Major Kolkata Blood Drive

  • By
  • June 10, 2025
Bonhooghly Yubak Sangha’s Roktodan Utsav Sees 2,545 Donors in Major Kolkata Blood Drive

Morari Bapu Becomes An Inspiration For Environmental Action

  • By
  • June 7, 2025
Morari Bapu Becomes An Inspiration For Environmental Action